| 名稱 | CD86/CHO |
| 型號(hào) | CBP74070 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CD86/CHO，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 如何正確的進(jìn)行ELISA試劑盒的操作
- 細(xì)胞株定期維護(hù)與監(jiān)測(cè)要做好哪些？
- IL-2藥物細(xì)胞篩選模型
- 【新品上線】一種安全高效的中和抗體體外篩選模型
- PLoS ONE：科學(xué)家發(fā)現(xiàn)癌癥轉(zhuǎn)移的新線索
- BRAF系列標(biāo)準(zhǔn)品
- PNAS：腫瘤細(xì)胞或可“拆用”間充質(zhì)干細(xì)胞來(lái)促進(jìn)乳腺癌復(fù)發(fā)
- 剛收到的細(xì)胞株如何進(jìn)行合理的處理？
- 細(xì)胞株有關(guān)細(xì)胞培養(yǎng)污染的控制
- 拯救偏頭痛！CGRP及其受體拮抗劑研究進(jìn)展
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74070CD86/CHO
- 詳細(xì)內(nèi)容
| CBP74070 | |
| I. Background | |
| B7-2 (CD86) signaling through CTLA4 (CD152) has been shown to inhibit T- cell activation. This co-inhibitory pathway can be overactive in many tumors, enabling cancers to escape the host’s immune system. CTLA4-blocking antibodies, including Ipilimumab (Yervoy) and Tremelimumab, have shown clinical efficacy in treating cancer. | |
| II. Description | |
Recombinant CHO cells constitutively expressing human CD86. | |
| III. Introduction | |
| Host Cell: | CHO |
| Expressed gene: | CD86 |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | T-lymphocyte activation antigen CD86, B7.2, FUN-1, B70, BU63, CD86, B72 |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS+500ug/ml hygromycin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Ligand of CD28&Binding Assay,FACS |
| IV. Description of Host Cell Line | |
| Organism: | Cricetulus griseus, hamster, Chinese |
| Tissue: | Ovary |
| Disease: | Hamster Chinese ovary |
| Morphology: | Epitheloid cell |
| Growth Properties: | Adherent |
| Ⅴ. Representative Data | |
Figure 1. Recombinant CHO cells expressing human CD86. | |
會(huì)員_a.png)